SCHEMBL19701973

SCHEMBL19701973

CC(C)c1cccc(N2CCN(S(C)(=O)=O)CC2(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.39
NOTUM Q6P988 2/20 0.38
CYP3A4 P08684 6/20 0.38
CYP2D6 P10635 5/20 0.38
ALOX15 P16050 1/20 0.38
CYP2C9 P11712 6/20 0.38
ALDH1A1 P00352 6/20 0.38
CYP1A2 P05177 5/20 0.38
USP2 O75604 5/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 2/20 0.38
RECQL P46063 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HIF1A Q16665 1/20 0.37
CYP2C19 P33261 4/20 0.37
TSHR P16473 2/20 0.37
DRD2 P14416 1/20 0.37
DRD3 P35462 1/20 0.37
KCNH2 Q12809 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19711202 0.83 SMN1; SMN2 (0.41) PIK3CDCYP3A4CYP2D6CYP2C9ALDH1A1
SCHEMBL19701981 0.78 ALDH1A1 (0.50) NOTUMCYP2C9ALDH1A1CYP1A2USP2
SCHEMBL19701949 0.77 PIK3CD (0.47) PIK3CDNOTUMCYP3A4CYP2D6ALDH1A1
SCHEMBL19701975 0.75 PIK3CD (0.43) PIK3CDNOTUMALDH1A1SMN1; SMN2HPGD
SCHEMBL19701972 0.74 NOTUM (0.41) PIK3CDNOTUMHPGDRECQLNPSR1
SCHEMBL19701971 0.74 PIK3CD (0.42) PIK3CDNOTUMCYP3A4CYP2D6CYP2C9
SCHEMBL27405111 0.72 DRD2 (0.41) NOTUMCYP3A4ALOX15ALDH1A1SMN1; SMN2
SCHEMBL27406469 0.71 NOTUM (0.39) NOTUMCYP3A4CYP2D6CYP2C9CYP1A2
SCHEMBL19702010 0.70 NOTUM (0.50) PIK3CDNOTUMCYP2C9ALDH1A1CYP1A2
SCHEMBL24721098 0.67 NOTUM (0.52) NOTUMALDH1A1SMN1; SMN2RECQLNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170355707-A1 BICYCLIC HETEROARYL AMINE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2017-12-14 US disclosed
US-20170355707-A1 BICYCLIC HETEROARYL AMINE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2017-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355707-A1 BICYCLIC HETEROARYL AMINE COMPOUNDS PIK3R3, JAK2, JAK3 PIK3CD 14/4885NOTUM 3221/4885CYP3A4 2210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.